Dr. Karl Deisseroth: Understanding & Healing the Mind

High-Level Overview

Andrew Huberman talks with Dr. Karl Deisseroth, a Stanford psychiatrist and bioengineer who still sees patients and whose lab pioneered optogenetics, the technique of using light-sensitive proteins from algae to turn specific brain cells on and off. Huberman explains that he started the podcast partly so he could have this conversation. They cover why psychiatry still depends almost entirely on words, where current treatments succeed, and the long, odd path from a 19th-century botanist watching algae swim toward light to restoring some light sensitivity in a blind human patient. They also discuss vagus nerve stimulation, brain-machine interfaces, ADHD and phones, the clearing technique called CLARITY, the brain basis of dissociation, and how psychedelics and MDMA might help. Deisseroth also describes how he protects time to think while running a lab of more than 40 people, seeing patients and raising five children.

The tone is curious, precise and quietly hopeful. Deisseroth is careful not to overclaim, and his optimism is grounded in the science. The conversation moves from the clinic to the lab and back again, and closes with his book Projections: A Story of Human Emotions, which uses patient stories to explain how the brain works.

The Discussion Explores:

• Why psychiatry, unlike neurology, relies on words, and how to get past jargon to real symptoms
• Warning signs such as early morning awakening, and the future of objective measurements
• Treatments that work well today, from CBT for panic disorder to antipsychotics and ECT
• How algae proteins became optogenetics, and a blind patient who regained some light sensitivity
• Vagus nerve stimulation, why precise targeting matters, and optogenetics as a guide for better drugs
• Brain-machine interfaces, ADHD, phones and the rule that a diagnosis requires impaired functioning
• CLARITY, the brain rhythm behind dissociation, and how psychedelics and MDMA might help
• Deisseroth's routine: protected thinking time, stillness and writing Projections

Deep Dive into Main Ideas

Psychiatry's Unique Challenge: Only Words

Deisseroth, who is married to a neurologist, explains the difference between the two fields. Neurologists can see the stroke on a scan or the seizure on an EEG. Psychiatry deals with disorders where "there's no blood test" and no brain scan that diagnoses schizophrenia or depression in an individual. "We've got the most complex, beautiful, mysterious, incredibly engineered object in the universe and yet all we have are words to find our way in." Reduced speech can itself be a symptom of depression, schizophrenia or autism, which makes diagnosis harder. The two fields also overlap. Parkinson's disease, caused by the loss of midbrain dopamine neurons, very often brings severe depression, which is not the case for ALS. Deisseroth co-treats Parkinson's patients with neurologists.

He expects quantitative tests eventually, including EEG-based rhythm measures now being developed, and thinks they'd be good for medicine while acknowledging they could be misused. The biggest current barrier, he says, is stigma: people feel they should handle problems on their own. Anxiety left untreated for a year or more can turn into depression as well.

Getting Past Jargon to Real Symptoms

Since patients use words like "depressed loosely, Deisseroth avoids jargon and asks about concrete experiences. How much do you look forward to the future? Are you making plans? Someone who says I can't even think about tomorrow is describing the hopelessness of depression precisely. He admits he never truly knows what's going on inside another mind, whether a mouse, a colleague or a patient, and often not even his own. The vegetative" signs of depression, sleep and appetite, only mean something against a person's baseline, since some depressed people sleep more and others less. Phones and wearables could provide baselines but raise privacy concerns. Family members often notice changes before the patient does. A classic early warning sign is early morning awakening: waking at 5, then 4, then 3 a.m. and being unable to fall back asleep, which patients may not connect to depression.

Treatments That Work, Found Mostly by Accident

Psychiatry has real successes, Deisseroth says. For motivated, insightful patients, cognitive behavioral therapy can treat panic disorder in roughly 6 to 12 sessions by teaching people to spot and derail the early thoughts that lead to a panic attack. Antipsychotics, despite their side effects, reliably clear up hallucinations and paranoia (the "positive symptoms of schizophrenia, meaning something added), though the negative symptoms such as withdrawal and thought blocking are harder to treat. Electroconvulsive therapy (ECT), now done under safe, controlled conditions, is extremely effective for treatment-resistant depression. But he's frustrated that it means causing a brain-wide seizure: How could you be less specific than that?" No one knows why it works.

Almost every psychiatric treatment was discovered by chance. Antidepressants, for example, began as tuberculosis drugs. Clozapine, often the most effective antipsychotic, acts on many receptors and has serious side effects, including blood cell problems that require regular blood checks, yet it works when nothing else does. Deisseroth says many psychiatrists have tried medications they prescribe to better understand side effects like sleep or libido disruption. Unlike cardiology, where we know the heart is a pump, psychiatry lacks a principle for what each brain circuit is for. For autism, for instance, he thinks the answer may lie in circuits that combine very high-bandwidth social information streams. He also says reports that fever temporarily improves autism symptoms are plausible, since a few degrees changes how every neuron behaves.

Optogenetics: From Algae in a Saucer to a Blind Patient

The story starts with a Russian botanist, Andrei Famintsyn, in the 1850s and 1860s, who noticed green algae in a saucer moving to just the right distance from a light, backing off when he made it brighter. The single-celled algae steer with flagella guided by a single light-activated protein. When a photon hits it, a pore opens and charged ions like sodium rush in. That is also how neurons switch on. Deisseroth's lab put the genes for these channelrhodopsins into specific types of neurons so light could turn those cells on (related proteins turn cells off), in real time, "just as a conductor" draws out particular instruments in an orchestra.

The work began in a dish in 2004. By around 2007 it was in behaving mice, and by 2009 the lab could make a mouse turn left and circle when the light came on and stop when it went off. Making it work took years: the proteins carry little current, so many had to be packed into specific cells without damage, and light had to be delivered safely. It has since been used in fish, rats, mice and monkeys. Recently, Botond Roska in Switzerland delivered a channelrhodopsin into the eye of a patient with retinal degeneration and gave him some light sensitivity he didn't have before, about ten years after he and Deisseroth showed it worked in donated human retinas. Deisseroth stresses that the wider clinical value is "indirect": learning which cells actually cause which symptoms makes any treatment, whether a drug, therapy or stimulation, more logical and specific.

Vagus Nerve Stimulation and Why Specificity Matters

Deisseroth performs vagus nerve stimulation in his clinic. A cuff around the vagus nerve in the neck, powered by a battery under the collarbone, sends signals toward the brain. Huberman is startled to hear that one main reason the vagus was chosen is simply that it's accessible, though it does connect to a relay station near serotonin and dopamine centers. It began as an epilepsy treatment and is FDA-approved for depression, but average effects are small, with some patients responding dramatically and others not at all. Deisseroth adjusts the dose by radio control during visits. He doesn't expect immediate mood changes. Instead he raises the intensity while checking that the patient can still breathe, swallow and speak normally, because the electrode affects everything nearby, which limits the dose. Benefits appear over days to weeks.

With optogenetics, only the right cells would respond to light, but first we need to know which cells to target. Gene delivery could use harmless engineered viruses called AAVs, with genetic switches that limit expression to one cell type, injected into a specific cluster of nerve cells, possibly as an outpatient procedure. Light delivery remains a challenge. Roska's patient needed special goggles that produce very bright light. Deisseroth's preferred future is actually better drugs. Optogenetics can identify the causal cells, for example those behind anhedonia or active versus passive coping, and then reveal their surface receptors so medicines can target them. Some existing, already-approved drugs may be repurposed this way within a few years.

He sees brain-machine interfaces, including deep brain stimulation, which already helps OCD, becoming more powerful as closed-loop systems that detect an early harmful activity pattern and stimulate only when needed. They are still invasive, though, and depend on knowing which patterns actually matter.

ADHD, Phones and When Something Is a Disorder

ADHD can be mainly hyperactive or mainly inattentive, with a still body but a darting mind. To be diagnosed, it must show up across settings like school and home, and EEG-based diagnostic tests are making progress. Huberman shares that he had a vocal tic as a child that still returns when he's exhausted, and asks whether phones and email could induce ADD-like symptoms. Deisseroth sees a parallel between the urge to check a phone and the building tension relieved by a tic. But every psychiatric diagnosis requires that symptoms disrupt social or occupational functioning, and "these days you know checking your phone is pretty adaptive," so compulsive checking can't be diagnosed as a disorder.

CLARITY, Dissociation and the Self

Deisseroth's lab also developed CLARITY, a form of hydrogel tissue chemistry. The lab builds a gel inside every cell of a brain, anchors proteins and RNA to it, then washes out the fats that scatter light. The result is a glass-clear brain with its molecules still in place. Huberman says he has looked at someone through one.

He cautions against assuming some human abilities can't be studied in animals. In a 2020 study involving both mice and humans, his lab found a circuit basis for dissociation, the separation of the sense of self from the body. More than 70 percent of people who have been through trauma experience it, and it appears in PTSD and borderline personality disorder. Dissociative drugs like ketamine produced it in mice: they still detected a stimulus but didn't seem to care. Recording and then playing back the activity pattern with light caused dissociation without any drug. An epilepsy patient at Stanford who dissociated before every seizure showed the same pattern in the corresponding brain region, and stimulating it produced the experience. In another study, activating only the cells in the visual cortex that respond to vertical bars made mice act as if they saw vertical bars when nothing was there.

Psychedelics and MDMA

Deisseroth supports carefully exploring psychedelics, which alter the experience of reality in fairly precise ways but can be addictive or cause unwanted lasting changes. He supports low doses and use alongside therapy when done rigorously, and notes their risks may not be much greater than what medicine tolerates elsewhere. His lab studies them under strict DEA oversight. His hypothesis: the cortex is "a hypothesis generation and testing machine," and many unlikely models are filtered out before they reach awareness. Psychedelics lower that threshold. In schizophrenia, faulty models escape and become paranoid delusions. In depression, where the future seems to run out "like a river just running out into a desert and drying up," loosening the filter may let new paths forward reappear, something his lab is testing by recording cells that represent future steps.

MDMA releases large amounts of dopamine and serotonin together. Deisseroth thinks the lasting benefit for trauma comes from learning. People see during the experience that connection with others is possible with fewer barriers, and they keep that knowledge after the drug wears off. Huberman compares this to good psychoanalysis, where new ways of relating are tested within the therapy relationship and then carried into life.

How Deisseroth Thinks, Works and Writes

Deisseroth came to the brain through a love of poetry, especially Borges, whom he read in both English and Spanish. He was amazed that words could create specific emotions even apart from their meaning. He planned to be a neurosurgeon and loved the precision of the operating room, but a required psychiatry rotation changed his course. He was struck by the depth of the suffering and the mystery that someone's reality could differ from his own when everything physical seemed the same.

He takes life "day by day, protecting at least an hour a day of phone-free thinking while sitting almost completely still. He can't imagine getting ideas while running, as some people do. He thinks verbally in near-complete sentences. While writing Projections he added midnight-to-2 a.m. writing sessions, used a distraction-free writing mode on his laptop, and sometimes spent days on a single word, cutting passages that were close but not quite right. When a sentence isn't working it feels aversive, but there's also a hope because I know I can solve it too." His goal was a book anyone could read that stayed rigorously within the science, and he says he is an optimist about where the field is heading.

Conclusion

Karl Deisseroth presents psychiatry as a field with real successes and big blind spots. Its best treatments were mostly found by accident and often work without anyone knowing why. Optogenetics, which grew out of algae swimming toward light, is changing that by showing which cells cause which symptoms, from active coping to dissociation. The payoff will come less from implanted lights than from understanding: more precise drugs, smarter closed-loop devices and a principled view of how psychedelics and MDMA help. Meanwhile, the practical lessons are to seek help early, pay attention to concrete signs like early morning awakening, and recognize, as Deisseroth's own routine shows, that deep thinking requires protected, undistracted time.

This is a summary of "Dr. Karl Deisseroth: Understanding & Healing the Mind" from Huberman Lab, giving you the GIST so you can decide if you want the REST. Listen to the full episode.